Published date: 30 January 2019
Last edited date: 30 January 2019
This notice was replaced on 21 June 2019
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 21 June 2019)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Peptones and protein substances - 24956000
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 33650000
Location of contract
Any region
Value of contract
£10,000
Procurement reference
tender_198898/741205
Published date
30 January 2019
Closing date
12 February 2019
Contract start date
13 February 2019
Contract end date
31 January 2020
Contract type
Supply contract
Procedure type
Open procedure (below threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Public Health England (PHE) seeking to procure the Borrelia miyamotoi antigens (GlpQ and Vlp15/16) for its South West Regional Laboratory.
If you feel that you can meet the above requirements or would like more information, then please access the tender documents via link: https://phe.bravosolution.co.uk/
More information
Links
-
- https://www.gov.uk/government/organisations/public-health-england
- Tender notice
- Information about our organisation
-
- https://phe.bravosolution.co.uk
- Tender notice
- Access to the tender documents
Share this notice
All content is available under the
